Charles River Laboratories International Inc

10 wrz 2026, 19:46 UTC

Charles River Laboratories is declining for a fourth consecutive session, influenced by macroeconomic factors and trading below its 20-day moving average.

9 wrz 2026, 23:36 UTC

Charles River Laboratories shares are trading slightly higher in after-market hours, despite remaining below their 20-day moving average after recent declines.

8 wrz 2026, 20:07 UTC

Charles River Laboratories International Inc shares declined during Tuesday's session, remaining near the lower end of their one-month trading range.

4 wrz 2026, 19:16 UTC

Shares of Charles River Laboratories International Inc. are lower today amid notable volatility and broader market concerns about potential Federal Reserve interest rate hikes.

3 wrz 2026, 23:01 UTC

Charles River Laboratories is higher in after-market trading, recovering from an initial dip and nearing the upper end of its one-month trading range.

2 wrz 2026, 22:02 UTC

Shares of Charles River Laboratories are lower in after-market trading following a volatile session. Broader market dynamics may be influencing the asset's movement.

1 wrz 2026, 22:06 UTC

Charles River Laboratories shares rose after-market, continuing to show resilience despite broader market pressure from rising bond yields and inflation expectations.

31 sie 2026, 20:07 UTC

Charles River Laboratories is lower today amid broader market pressures from inflation concerns and potential interest rate hikes following the Jackson Hole Economic Symposium.

28 sie 2026, 23:36 UTC

Charles River Laboratories is advancing in after-market trading, continuing its upward movement since Friday's close amid broader market dynamics. No specific news was identified.

27 sie 2026, 22:01 UTC

Charles River Laboratories shares are higher in after-market hours, reflecting a positive trend despite earlier session volatility. Market factors remain under close observation.

26 sie 2026, 19:16 UTC

Charles River Laboratories reports first-quarter revenue of $1.03 billion, missing estimates. Shares are lower amid sector declines and ongoing inflation concerns.

25 sie 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, maintaining a position near the upper end of their one-month range amid lower crude oil prices.

24 sie 2026, 19:16 UTC

Charles River Laboratories is trading roughly flat amid a notable decline in Agilent Technologies. Market focus is on upcoming events, including a Federal Reserve speech.

21 sie 2026, 23:01 UTC

Charles River Laboratories shares declined in after-market trading, amid broader market volatility tied to rising U.S. Treasury yields and inflation concerns.

20 sie 2026, 19:41 UTC

Charles River Laboratories partners with Medigen to develop a multivalent enterovirus vaccine, supporting regulatory readiness and non-clinical studies. Shares are trading higher.

19 sie 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, reaching a notable increase since Wednesday's close and positioning near the upper end of its one-month range.

17 sie 2026, 19:26 UTC

Charles River Laboratories shares are higher today, continuing an upward trend since Friday's close. The stock remains near the top of its one-month trading range.

14 sie 2026, 19:46 UTC

Charles River Laboratories shares are lower amid broader market declines following a drop in U.S. retail sales, indicating potential weakening consumer demand.

13 sie 2026, 19:52 UTC

Charles River Laboratories shares are lower today amid rising jobless claims and volatility, reflecting a decline since Wednesday's close.

12 sie 2026, 20:51 UTC

Charles River Laboratories is higher in after-market trading, reflecting positive momentum despite no specific news. Broader market dynamics appear to support this resilience.

11 sie 2026, 19:56 UTC

Charles River Laboratories International Inc. shares are trading higher today, maintaining a position above the 20-day moving average amid routine price movements.

10 sie 2026, 19:16 UTC

Charles River Laboratories shares rise as TD Cowen and Mizuho raise price targets to $300 and $264, respectively. The stock shows notable strength since Friday.

7 sie 2026, 19:51 UTC

Morgan Stanley raised its price target on Charles River Laboratories to $300, maintaining an Overweight rating as shares move higher since Thursday's close.

6 sie 2026, 22:51 UTC

Shares of Charles River Laboratories International Inc. are lower in after-market trading, continuing a decline from Thursday's close despite being above its 20-day moving average.

5 sie 2026, 23:56 UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

4 sie 2026, 19:16 UTC

Charles River Laboratories is rising amid positive momentum in the small-cap market, supported by a drop in crude oil prices that eases inflation concerns.

3 sie 2026, 22:06 UTC

Charles River Laboratories shares are slightly higher in after-hours trading, supported by stronger-than-expected manufacturing data showing a rise in the PMI for July.

31 lip 2026, 19:46 UTC

Charles River Laboratories reported first-quarter revenue of $1.02 billion and adjusted EPS of $2.06, but shares are lower amid broader market declines.

30 lip 2026, 23:01 UTC

Shares of Charles River Laboratories are higher in after-market trading, reaching a peak above Thursday's close and remaining strong relative to recent trends.

29 lip 2026, 19:18 UTC

Charles River Laboratories is lower today amid broader market declines and investor caution ahead of the Federal Reserve's monetary policy announcement.